The introduction of nicotinamide as a nicotine substitution in e-cigarette and smokeless products and solutions signifies a significant regulatory challenge with the FDA. Nicotinamide doesn't have nicotinic receptor agonist exercise and is understood to work as a sedative at substantial dosages6. The claims created by Nicotine River, ECBlend, along